| | | | | |
UP Wheels Up Experience Inc. | €6,3267 | +1,60% | €225,80M | €10,99K | |
NUS NuSkin Enterprises, Inc. | €4,7742 | +1,47% | €225,49M | €120,09K | |
AIRO AIRO Group Holdings, Inc. Common Stock | €7,2081 | -3,43% | €225,46M | €98,90K | |
ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | €3,1318 | +1,15% | €225,34M | €90,97K | |
| €2,4823 | -1,37% | €224,83M | €114,83K | |
DEFT Defi Technologies, Inc. | €0,46964 | +2,45% | €224,74M | €381,84K | |
FACT FACT II Acquisition Corp. Class A Ordinary Shares | €9,1939 | -0,28% | €224,66M | €876,14 | |
| €3,1266 | +7,59% | €224,21M | €69,60K | |
| €14,0780 | -2,12% | €223,94M | €21,25K | |
SABS SAB Biotherapeutics, Inc. Common Stock | €2,9536 | +1,64% | €223,53M | €29,10K | |
TWFG TWFG, Inc. Common Stock | €18,7597 | +5,04% | €223,36M | €31,26K | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | €4,7751 | +0,38% | €223,00M | €15,50K | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,2025 | +0,00% | €222,88M | €7,11K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1766 | +0,09% | €222,77M | €25,98K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1939 | +0,00% | €222,55M | €92,54 | |
